Founded in 2018, TMRW is a life sciences technology company providing a next-generation, automated, software-guided specimen management solution for the safe management of frozen eggs and embryos central to the IVF process. For the first time, frozen eggs and embryos can be digitally identified and tracked, safely managed with automated robotics and remotely monitored 24/7. With proprietary RFID-enabled labware and an integrated software management solution, TMRW empowers clinics and gives peace of mind to patients on their fertility journey. TMRW, named Fast Company's #1 Most Innovative Biotech company in 2022, has been adopted by leading clinics across the US and will soon be available in the UK and Europe. With significant continued growth in fertility services and the projected number of IVF births on the rise, TMRW provides a scalable solution for clinics bringing the care of frozen eggs and embryos into the 21st century.